Literature DB >> 26523112

Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis.

Salvatore Annunziata1, Daniele Antonio Pizzuto1, Carmelo Caldarella1, Federica Galiandro1, Ramin Sadeghi1, Giorgio Treglia1.   

Abstract

AIM: To meta-analyze published data about the diagnostic accuracy of fluorine-18-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET) and PET/computed tomography (PET/CT) in the evaluation of primary tumor in patients with gallbladder cancer (GBCa).
METHODS: A comprehensive literature search of studies published through 30(th) June 2014 regarding the role of (18)F-FDG PET and PET/CT in the evaluation of primary gallbladder cancer (GBCa) was performed. All retrieved studies were reviewed. Pooled sensitivity and specificity of (18)F-FDG PET or PET/CT in the evaluation of primary GBCa were calculated. The area under the summary receiving operator characteristics curve (AUC) was calculated to measure the accuracy of these methods. Sub-analyses considering the device used (PET vs PET/CT) were carried out.
RESULTS: Twenty-one studies comprising 495 patients who underwent (18)F-FDG PET or PET/CT for suspicious GBCa were selected for the systematic review. The meta-analysis of 13 selected studies provided the following results: sensitivity 87% (95%CI: 82%-92%), specificity 78% (95%CI: 68%-86%). The AUC was 0.88. Improvement of sensitivity and specificity was observed when PET/CT was used.
CONCLUSION: (18)F-FDG-PET and PET/CT demonstrated to be useful diagnostic imaging methods in the assessment of primary tumor in GBCa patients, nevertheless possible sources of false-negative and false-positive results should be kept in mind. PET/CT seems to have a better diagnostic accuracy than PET alone in this setting.

Entities:  

Keywords:  Fluorine-18-fluorodeoxyglucose; Gallbladder cancer; Positron emission tomography; Positron emission tomography/computed tomography

Mesh:

Substances:

Year:  2015        PMID: 26523112      PMCID: PMC4616223          DOI: 10.3748/wjg.v21.i40.11481

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  Role of 18F-FDG PET/CT in detecting recurrent gallbladder carcinoma.

Authors:  Rakesh Kumar; Punit Sharma; Anita Kumari; Dhanapathi Halanaik; Arun Malhotra
Journal:  Clin Nucl Med       Date:  2012-05       Impact factor: 7.794

2.  Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma.

Authors:  Henrik Petrowsky; Peer Wildbrett; Daniela B Husarik; Thomas F Hany; Simona Tam; Wolfram Jochum; Pierre-Alain Clavien
Journal:  J Hepatol       Date:  2006-04-19       Impact factor: 25.083

3.  Positron-emission tomography with fluorine-18-fluoro-2-deoxy-D-glucose for gallbladder cancer diagnosis.

Authors:  Antonio Rodríguez-Fernández; Manuel Gómez-Río; José Manuel Llamas-Elvira; Simeón Ortega-Lozano; Jose Antonio Ferrón-Orihuela; Jose Manuel Ramia-Angel; Alfonso Mansilla-Roselló; María Dolores Martínez-del-Valle; Carlos Ramos-Font
Journal:  Am J Surg       Date:  2004-08       Impact factor: 2.565

4.  Feasibility of (18)F-fluorodeoxyglucose positron-emission tomography for preoperative evaluation of biliary tract cancer.

Authors:  Isamu Yamada; Tetsuo Ajiki; Kimihiko Ueno; Hidehiro Sawa; Izuru Otsubo; Yuko Yoshida; Makoto Shinzeki; Hirochika Toyama; Ippei Matsumoto; Takumi Fukumoto; Atsunori Nakao; Joji Kotani; Yonson Ku
Journal:  Anticancer Res       Date:  2012-11       Impact factor: 2.480

5.  Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study.

Authors:  Andrew X Zhu; Jeffrey A Meyerhardt; Lawrence S Blaszkowsky; Avinash R Kambadakone; Alona Muzikansky; Hui Zheng; Jeffrey W Clark; Thomas A Abrams; Jennifer A Chan; Peter C Enzinger; Pankaj Bhargava; Eunice L Kwak; Jill N Allen; Sanjay R Jain; Keith Stuart; Kerry Horgan; Susan Sheehan; Charles S Fuchs; David P Ryan; Dushyant V Sahani
Journal:  Lancet Oncol       Date:  2009-11-20       Impact factor: 41.316

6.  Does PET-CT scan have a role prior to radical re-resection for incidental gallbladder cancer?

Authors:  Parul J Shukla; Savio G Barreto; Supreeta Arya; Shailesh V Shrikhande; Rohini Hawaldar; Nilendu Purandare; Venkatesh Rangarajan
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

7.  Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma.

Authors:  Hiroyoshi Furukawa; Hiroki Ikuma; Koiku Asakura; Katsuhiko Uesaka
Journal:  J Surg Oncol       Date:  2009-11-01       Impact factor: 3.454

8.  Preoperative staging of biliary carcinoma using 18F-fluorodeoxyglucose PET: prospective comparison with PET+CT, MDCT and histopathology.

Authors:  Hiroyoshi Furukawa; Hiroki Ikuma; Koiku Asakura-Yokoe; Katsuhiko Uesaka
Journal:  Eur Radiol       Date:  2008-05-29       Impact factor: 5.315

9.  Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma.

Authors:  Christopher D Anderson; Michael H Rice; C Wright Pinson; William C Chapman; Ravi S Chari; Dominique Delbeke
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

10.  Primary tumor maximum standardized uptake value measured on 18F-fluorodeoxyglucose positron emission tomography-computed tomography is a prognostic value for survival in bile duct and gallbladder cancer.

Authors:  Ji Yong Lee; Hong Joo Kim; Seo Hyung Yim; Dong Suk Shin; Jung Hee Yu; Deok Yun Ju; Jung Ho Park; Dong Il Park; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim
Journal:  Korean J Gastroenterol       Date:  2013-10
View more
  4 in total

1.  Radio-pathological Correlation of 18F-FDG PET in Characterizing Gallbladder Wall Thickening.

Authors:  Vikas Gupta; K S Vishnu; Thakur D Yadav; Yashwant R Sakaray; Santosh Irrinki; B R Mittal; N Kalra; K Vaiphei
Journal:  J Gastrointest Cancer       Date:  2019-12

2.  Computed diffusion-weighted magnetic resonance imaging with high b-values in the diagnosis of gallbladder lesions.

Authors:  Motokazu Sato; Yusuke Kurita; Eiji Sakai; Seitaro Watanabe; Haruto Sanada; Tomoki Shimizu; Kenji Kanoshima; Yusuke Takai; Koki Meguro; Yuichi Sugimoto; Yusuke Biwata; Kunihiro Hosono; Noritoshi Kobayashi; Kensuke Kubota; Atsushi Nakajima
Journal:  Abdom Radiol (NY)       Date:  2022-06-29

Review 3.  Evidence-based management of incidental focal uptake of fluorodeoxyglucose on PET-CT.

Authors:  Deborah Pencharz; Malavika Nathan; Thomas L Wagner
Journal:  Br J Radiol       Date:  2018-01-31       Impact factor: 3.039

4.  The Role of 18F-FDG PET/CT in staging of gallbladder carcinomas.

Authors:  Esra Arslan; Tamer Aksoy; Nevra Dursun; Rıza Umar Gürsu; Mert Mahsuni Sevinç; Tevfik Fikret Çermik
Journal:  Turk J Gastroenterol       Date:  2020-02       Impact factor: 1.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.